He painted a huge mural in dover. News 24 hours a day, powered by more than 2600 journalists in more than 120 countries. Im Alisa Parenti, and this is bloomberg. Emily this is Bloomberg Technology. Im emily chang. On this week, bloomberg tv and radio are on the ground in boston showcasing tech giants and startups, plus Breakthrough Technologies in biotechs and robotics. We are speaking with innovators, venture capitalists, and government officials across the city. Caroline joins us from outside the museum of science in boston overlooking the Charles River. Caroline, i see spring has not quite sprung in boston. You are all bundled up. Caroline you are right. Its a touch chilly, but beautiful nonetheless. Indeed, the sun breaks out for us, a special edition of Bloomberg Technology for you. Welcome from the ever Popular Museum of science, welcoming more than 1. 5 million visitors a year. I had way too much fun playing on the musical steps. But i digress. Today we will take a look at the massachusetts biotech sector. Meantime, while the Trump Administration has proposed cuts that could hamper future growth, and many local companies are opposing the president other initiatives, such as the Affordable Health care act and the tightening of h1b visa restrictions. For a look at how local companies are responding, we are joined by our bloomberg biotech reporter doni bloomfield, and hasenture capitalist who thank you for joining me. Paint the picture for us. We keep talking about boston as a biotech hub. Which company should be on the agenda here . I think some of the Central Companies here are biogen, varitek, some of the Largest Companies are based here. So many little Tiny Companies spring up all around them and around universities around here. I think the trends we should be looking at are the moves towards rare diseases. We talk so much about pricing in this industry, and there has been so much pressure, but some of the focus resistant to the trend are those focused on rare diseases. Insurers and payers are a lot less willing to fight back against very high prices. Vertech, varitek treats cystic fibrosis. Biotech biogen came out with a new drug for a deadly muscle disease. The first year of treatment is 750,000. These are areas local Pub Companies are pushing into and across the country as well. Caroline when you are helping in such crucial areas, theres also plenty of money that needs to go into funding these longterm bets. How much of the system have you been looking at, and how much is it growing . The ecosystem is booming. Epicenterthe absolute of biotechnology. Every Major Pharma Company has research and development here. It is education. You have 50 colleges in the boston area, 200,000 students come here. Fromnvinced them to move around the world to a place with great weather. They stay. It makes incredibly Fertile Ground for funding. Caroline maybe not for our funding from the government at the moment. Top to us about the concerns that have come in. Nih seems to have kept the money flowing for the short term. There is worry about the Affordable Care act changes, and the Trump Administration and their viewpoint on health care in general. Reporter a lot of local companies have Major Concerns about the immigration orders, which has been stayed by the courts, because attracting people needs people from all over the world. As there are problems because of religion or country of origin, that will be an issue for innovation around the area. That is what a lot of the companies have said. When it comes to pricing, i think some of the concern around the changes to obamacare in this act that just passed the has still needs to go through the senate. In that case, they still concerns we could get lifetime limits back. These are limits on how much insurers will pay for it patient care. We are talking about a drug that could potentially cost 350,000 or more a year. That adds up very quickly. I think thats a major concern for some Companies Moving into these rare diseases, because if those lifetime limits are back, they will be facing major struggles when people hit their caps. You have a perspective on not overnight success stories. How can you factor in the politics . It is important, because no city feels Health Care Funding like boston. The top four funded from nih are in boston. When the funding dries up, it means people who are entrepreneurs and want to Start Companies will think about private funding, and we are there to fill the gap. Caroline how much are we seeing the vc Community Expand here in boston . Many feel that Silicon Valley is just so much of a bigger brother. Are you seeing people coming from there, or is there a building up of money to build support . In Traditional Technology, Silicon Valley, where we also have offices, is of course, the big brother. It might actually be the grandfather. However, in biotech, this is the center. You see venture capitalists swarming from around the country because we have the three ingredients. Universities that draw students, big pharma which bills of clusters of entrepreneurial excellence, and radically decreasing costs of building a company in this space, which means that if you are a young researcher at one of these companies and you have an idea, it doesnt require 50 million to see whether it works. Caroline do you inc. Theres any International Money coming in . Reporter there is International Money coming in. , forample of clustering is example, crispr, the gene and ending gene editing technology, they have Research Centers in cambridge. That is because of the clustering effect going on. Caroline lastly, when you are looking at how the investments you continue to make, where are you looking to in terms of exit . Are we seeing money getting refueled back into the system . Are we seeing m a . Are we seeing ipos . The ipo market has been muted at best, but we are seeing an opening of a window. In biotech, it has been wide open. Thats where the reasons you have venture capitalists moving into biotech. It used to be silos with health care on the other. Now with the powers of Machine Learning and ai, we are seeing the converging of the spaces. Caroline and you are in a number of companies. 400 startups at least. Which Company Portfolios should we look at . Is making, pilpac fundamental changes to the labor history prescription drugs are covered. The bay areaer in which is changing peoples access to doctors reports and theing, using the power of data. I think the resounding theme is the convergence of Traditional Technology with health care. Caroline it has been great having youcaroline welcoming the cold. Much. You very it has been great. From bloomberg. Thank you. Lets take a quick look at todays top tech headlines. Amazon has just unveiled the echo show, which is voiceactivated, and a seven inch touchscreen. Lastported on this device november. You can have calendar appointments, display music, and play videos. It is the first echo speaker with a builtin camera that makes video comment conferencing possible. It will be available late next month and will be the fifth product powered by alex appeared from bostonse tech scene with the president from the director of the museum of science here in boston. He joins us to discuss how the world renowned culture it inspiring the next batch of Tech Innovation and engineers. All episodes of Bloomberg Technology, are Live Streaming on twitter. Check us out weekdays 5 p. M. In new york and 2 p. M. In san francisco. This is bloomberg. Caroline welcome back to this special edition of Bloomberg Technology, live from the Boston Museum of science, a cornerstone in maintaining and growing the citys tech ecosystem, passing the love of innovation and science to the next generation. We are in a place that is aiming to do just that. Museum of sands offers programs and interactive exhibits and introduces more than 1. 5 million annual visitors. Earlier, i spoke to dr. Yana cialis yana the director of the Boston Museum of science. Most ofge range that the visitors fall our children, from five years old to about 14 years old, with their parents, along with school groups. But what is appealing to people of all ages is that we dont only present science and how the Natural World works, but also engineering, how the human world works, and how the two interact together. Caroline how is technology wrapped up in the way science is consumed here . We present technology and science as the total world, existing together. We have a fabulous new guide that presents how technology and science exists, and how the Natural World and human made world has made this environment here on the Charles River possible. It is the perfect example of the interaction between Natural World and human made world. Caroline top to us about how the ecosystem works with the museum of science and you feedback into it. Boston is a fabulous city for science and technology, and a great city to live in. We had some of the best universities, hospitals, corporations, and the hightech area and technology area. The museum offers a wonderful window to the public. We partner with a lot of companies and universities to present the wonderful work they do in technology development. Emily how have you found funding caroline . How have you found funding . We have been very fortunate to have sources, lots of corporations, and philanthropy. We are the number one funded institution from the federal government. Money is very important for what we do, but because of the kind of work that we do and the engagement we offer to funding sources, we have been very fortunate. Caroline the willingness to give, how much is that wrapped up with the willingness for diversity . Part of the reason why we might not have as much diversity in the tech world is that stem is not being educated the way it should be. One of our Top Priorities is to present science and engineering in a way that is equally appealing to both boys and girls and men and women, and to present science anyway that would be appealing to groups coming to the science center. We have been very fortunate. To give an example, one of my favorite exhibits is where children can spend about half an hour designing and building something, competing with each other. One would think boys would be more interested in that, but we have more girls that are interested in the engineering activity. Caroline you are very much talking about the role in education. How do you see yourself . It is not just more than one Million People walking through the doors every year, is 12 million your educating worldwide. I want to get your focus on where it goes globally. Have amuseum does wonderful platform to introduce engineering as a discipline into childrens lives all over the world. We started this endeavor when i came here in 2003, and now have become the primary driver of engineering for children worldwide. We developed a curriculum being used for 14 million children. We have trained about 150,000 teachers. Now we operate internationally. Caroline how much bigger can that become . What is your outlook for the next 10 years . Everydream is to have child, anywhere in the world, to the understanding of Natural World and human made world and have engineering become a part of every childs life. Engineering offers a wonderful way to learn how to problem solve which is a skill you can use anywhere. In todays environment, we have concerns about the administrations dedication to the funding of biotechnology, is it something that worries you . It is a concern, of course. What i have seen through the years is if you do good work and stick with it, it is not a big issue. You can plow through it. Was Boston Museum of science president and director ioannis miaoulis. Softbank is said to be close to completing its Technology Fund as early as next week, up to 95 billion. Company like apple and qualcomm have previously said they are investing money into the japanese company. Up, gene editing is seen as the next big breakthrough in medicine, and there are three massachusettsbased firms working on it. We will bring you details on the Companies Using crispr. From boston, this is bloomberg. Caroline welcome back to a special edition of Bloomberg Technology, from boston. Crispr is a new gene editing tool that could transform biotechnology. The technique and its dna with unprecedented accuracy, and hopefully will play a big role in medicine. Doni bloomfield started with three companies in massachusetts raising to use crispr in real life, and proves it can work with treating disease. Reporter the gene editing tool crispr is boosting crops, tweaking the genetics of mosquitoes, and creating lyme disease proved mice. Now companies are racing to use the technology for humans. Is, in my lifetime, probably the most exciting single invention i have seen. These are the only public crispr companies in the u. S. , all with labs in a three mile stretch of cambridge, massachusetts. Crispr is a technology to accomplish what is called gene editing. This is for patients with diseases caused by mistakes in the dna. The ability to go to the level of dna and repair the broken gene. Biotechnologies, which all went public last year, and to first Test Technology and relatively simple genetic diseases, where a small genetic tweak can cause devastating damage. In essence , how this works is think of a gps localization signal or a zip code. You put is a code onto what we call a pair of molecular scissors. The scissors dont work until the zip code delivers the molecular scissors to the part of the region or genome we are targeting it to. Reporter Crispr Therapeutics and edit toss want to start human trials by 2018. Crispr is moving at a rapid pace. If you ask two years ago how long it would take to get to the stage, it would be longer. Reporter Crispr Therapeutics wants to start by genetically engineering the cells of people with rare Blood Disorders outside the body before putting them back in. Inject crisprs to tools into the eyes of people with a rare form of genetically caused blindness. His company hasnt given a timeline for when it will put products into people. You are the fact that modifying dna, which we have not been doing with other therapeutic approaches, there are considerations we need to be thoughtful about. Reporter scientists in china are moving faster. Researchers there started the first crispr human trial last year. They used crispr to modify the g malone genome of human embryos. Where do you juggle line draw the line . That it is a potential curative treatment versus an enhancement to an individual. Reporter for now, the three leading crispr companies in the u. S. Are focusing on tackling disease, and they are in a complex fiddles series of battles in the u. S. And europe. The issue is about inventor ship. Who actually invented this . Reporter with the academic groups behind crispr and intelia on one side, and editas. On the other side. Last year, they fended off a challenge from the uc berkeley and the u. S. To keep both alive for now. Intelia and crispr are appealing the decision. It is too early to say which companies are going to be best at developing drugs at this stage of developing medicines. Reporter ultimately, human trials in the next three years will tell us more about how this revolutionary technology will change their genes and our health. I think the impact, we are only beginning to understand it. There are 6000 genetically diseases. 95 of them have no approved medicine. Its a very long list of patients who could potentially be helped by this. Was doni that bloomfield, fascinating stuff. Coming up, we take a look at bostons biotech scene even further with ceo nick leslie. Talk about why the company chooses boston about a place to develop its business. If you like bloomberg news, check us out on the radio. You can listen on the Bloomberg Radio app, bloomberg. Com, and in the u. S. On sirius xm. This is boston, and this is bloomberg. Alisa im Alisa Parenti in washington. You are watching Bloomberg Technology. Bloomberg technology. Lets start with a check of first word news. The white house is congratulating south koreas new president. Press Secretary Sean Spicer says the administration is looking forward to working with moving moon to strengthen the alliance between the two countries. Says they will meet again in bethlehem. The president has accepted the invitation to join him in the west bank city during his visit to israel in two weeks. Senate republicans are getting down to work on their version of obamacare. Senate Majority Leader Mitch Mcconnell says action is needed now, because Health Markets are collapsing. Democrats sent a letter to mcconnell asking him to drop repeal and replace legislation. French police are searching for three men suspected of hiding plotting and Islamic State attack. Authorities conducted a major operation at a train station. The evacuation of the station came a day after the 10th president ial election, won by macron, saying that his priority will be entering frances security. Global news 24 hours a day, powered by more than 2600 journalists in more than 120 countries. Is Alisa Parenti, this bloomberg. It is after 5 30 p. M. Here in washington. We are joined by paul allen. That is where keys in sydney with a look at the markets. Aul good morning. We are seeing strengths on the nikkei futures out of chicago and osaka. So for asx futures, pointing down about two thirds of 1 . This is after the broader asx fell half a percent yesterday. Dragged down by the banking stocks. Commonwealth bank down almost 4 , and it makes up almost 9 of the asx by weight. If that goes, the risk of other markets photos follows. Im in canberra, because last night we had the australian budget handed down and that contained a, liability level on the banks raising 4. 6 lien dollars over the next four years. Also the budget we see a deficit of 21 billion u. S. Dollars. The australian budget expects to return the so plus surplus by 2021. Cpi and ppi, china for april, and south korean unemployment figures. Im paul allen here in canberra. More from Bloomberg Technology, next. Caroline welcome back to this special edition of Bloomberg Technology. Im caroline hyde. We are live from boston all this week, showcasing the innovation, diversity, and power of the cities tech economy. One thing boston is known for is the booming biotech scene. One major player in the scene is bloomberg bio. The companys platform and company is in geneediting. Glaxosmithkline will pay undisclosed sums to license technology to delivering genetic material sending us is. The ceo of bloomberg bio, nick leslie. Its a little chilly for us. Therapy,ow your gene visavis the competition in boston or abroad, compares. Gene therapy is a broad space. Come is the impact it is having on patients. Of geneept and promise therapy is to alter disease, potentially cure disease. That is the big differentiator. There are some really terrible ableses and we have been to announce small numbers of patients, but going from not but ameliorating, potentially curing the patient s and giving them a lifeline benefit. Thats what all of us have been rooting for. That is what bluebird is all about. That is what we are trying to do. As a whole class of us trying to really do something important for patients. Caroline and doing it here in boston and the greater massachusetts area. How important has the ecosystem been for you and some of your rivals or for enemies . I think we are all trying to do the same thing, but boston is fabulous. It has developed into an ecosystem where you have everything you need. It starts with academia and ideas with research and innovation that comes with it. That moves to the medical institution and translational nature it brings, and how it along with it. Then you have investors who start to see it, and Companies Just like bloomberg, bluebird. Then you have public investors and others that can help carry it to the next stage. Then you have biofarma and pharmaceuticals. The rmb centers are here. Nd centers are here. Talent, how much at the moment is that an area of optimism, or is there any concern, particularly with the administration clamping down on immigration . That is an important context. Talent to disease has to come from a global pool. Its not all going to be in boston. Theres a lot of people coming here to study, and would like to stay here to continue their research or ideas. That is important. That wherever we went politically, that we have an open gate towards innovation. That is something that a company like bluebird has benefited from. That is something we are trying to actively support and encourage. Boston in and of itself has been incredibly supportive. Im not worried about the talent pool, but it changes. As we get bigger, some people who love working with bluebird want to go back and work on another thing. Thats ok. It creates help each other or. Healthy turnover. Its fun to be a part of. Caroline and perhaps people going off to spurn other new stuff. What about your previous role as a vc . What about the system of money being built here in massachusetts . Is it starting to build, does it need to . Are you waiting for International Money to flow in . I think it has been here for some time. It has been here in the i. T. And tech sector, and then with biotech right now, it is heavy on the biotech side. But there are different types. There are earlier Stage Companies like atlas or polaris. They tried to foster and companies. Smaller dollars, and then as they get bigger, you need bigger investors. You need fidelitys of the world to carry you to the next step. It is here, it is just a matter of selecting their right ideas and cultivating them. You went public. Does it do these longterm bets that biotech, bloomberg i nature, bio, in its does . Im sure you know the quote, you get the investors you deserve. It the company that cultivated itself with a longterm vision. It is a constant struggle as a ceo. One of the things i dont love is the shortterm horizon that you have to understand. You dont necessarily have to operate the company for that shortterm, because you do have to take a position on where you want to be in three years or five years. That is where bluebird is. You have to be cognizant of both. That is a reasonable pressure. Everyone has to do their part. You can be worried about 10 years from now when you have a lot of investors that have supported the company. You have to be cognizant of that. That is a natural tension that we all have to consider and respect. Caroline what about three to five years . You said you have to be looking at that time frame. Withto us about a deal glaxosmithkline. How does your business continue to evolve . That is an interesting one that dates back to the innovation we talked about and some of the early stage ip in the field, in our case, gene therapy, where we looked to use a particular virus. Now it has become a part of many therapies and other programs for important diseases that glaxo is working on. One of the things we dont want to stand in the way of is to take those forward to patients and provide youth. That is what the nature of the to participate and share intellectual property with them. Thats a good thing. We are focused on the main driver for bloomberg, try to do what they are doing, creating products that make a big difference for patients. That is what our shareholders are expecting from us and the standard we hold ourselves to. Caroline wonderful to have you with us. Thank you for sticking on with us in the cold. Nick leslie, the bluebird bio ceo. Facebook famously started by Mark Zuckerberg in a harvard dorm room, is perhaps considered by bostons tech community, the one that got away. Facebook quietly returned to cambridge in 2013 to open an engineering office. Today, more than ever, the company is taking advantage of town. P talent in the Kendall Square in cambridge is the heart of bostons tech community. West Coast Software giants have taken note, establishing a presence here. Facebook is always looking for an opportunity to hire the best talent. We came here because boston is a town of talented senior engineers and great universities. Caroline ryan mac helped open the office nine years after facebook was formed. Has grown, employing about 100 engineers, tackling their toughest challenges. Most of what we are working on in boston is infrastructure. Two thirds are working on the technology that is the underpinning for the products that people see on a regular basis. Caroline he breaks it down into four pillars. Storage, security, networking. They need to develop the applications to reach facebooks 1. 8 billion users. To Cambridge Team also support some of the social networks projects like the live interactive comment stream. When you post a comment on a video and facebook, anyone else looking at the video will see the comment in realtime. Caroline and locationbased products like Facebook Live video matt and marketplace that helps users buy and sell locally. The Global Company with a market billion, the worlds fifthlargest, has even more ambitious aims in the outlook. We can get more people a voice. Caroline along with the engineering teams and headquarters in menlo park, seattle, london, and new york, the Cambridge Team will play its part particularly in canada to be. How do we get conductivity to people . One billion we are doing that by building up foundational technologies to build an ecosystem outside of facebook to make cellular Wifi Technology is cheaper. We are trying to change the cost curve to deliver them to places that dont have network availability. Caroline social networking on the global and local scale. Coming up, disney reports secondquarter results. We hear from ceo bob iger next. From boston, this is bloomberg. Caroline breaking news from boston. James comey has been removed from heading the fbi. This is a statement from sean spicer, coming from the president. President donald j. Trump has informed director james comey has been terminated and removed from the office. President trump acted unclear recommendations. Is one ofrump says, the nations most cherished institutions, and today will mark a new beginning for our crown jewel of law enforcement. Search for the new permanent fbi director will begin immediately. With that, we turn our attention to a different focus. Of course, earnings day for the aftergiant disney, and the close, profit in the quarter declined as the Cable Division continues to move subscribers. Lets go to my colleague david westin in new york, standing by with the disney ceo bob iger. Reporter we do have bob iger, chairman and president of the walt disney company. Welcome back to bloomberg. Good to have you here. Thank you. Reporter you got your earnings out. Thati took away from it is you exceeded the expectations with respect to profitability earningspershare. While a little short of whats expected on revenue. Lets start with where you really had to beat on the earnings. It looks like a story of the parks and studious. It is the story from where i said sit from the quarter we just announced. 21 . Of those units were up parks and resorts up 20 , studios of 21 . Continued trend in the marketplace that is positive. Certainly, tourism and visitation to the parks across the globe, and a product of the marketplace that is working. On the studio front, it is the result of years that are smart investments, like acquisitions fantasticlm, and firstrate team across the board. Reporter on the theme park subject, houston said is the business to Consumer Spending . This in a little softness in the last week or two. Clearly, healthy consumer is good for walt disney companys business, by the van case vacations and experience we offer are extremely unique, something that consumers covet, in some cases they save up for a long period of time. Its part of longterm planning in their lives for a vacation or celebrating something else. Lesstend to sacrifice that than other things. We also rely on consumers, not just from the u. S. , but from across the globe. We also rely on the intellectual property and storytelling we create is a company. Thats a lot in the parks leverages the great storytelling of the studio and remains in demand, even when times are a little more difficult economically. Reporter shanghai was something near and dear to your heart. I understand it is now profitable already. It is exceeding expectations. You always expand something working. I know theres already plans to expand on shanghai are you doubling down, or thinking about additional parks in china . This is a important projects for me. I worked on it for over 17 years. Im extremely proud of what the team ultimately designed and created. Im also proud of how it has been operated in the first year and proud of how the Chinese People have taken to it. We are probably just a few days away from hitting 10 million in attendance. It had been our target for the first year. We celebrated the first Year Anniversary in midjune. We are running ahead of where we hoped we would be. About two thirds of the is fromce from outside the shanghai area. That is interesting. A national this is destination. We expected to thirds of attendance to be within the shanghai region. That is encouraging. We have a piece of land that is very large in terms of not only the sides, but the ability to build it out, and a willing partner to enable us to do that. We announced expansion before we opened, we announced so we are building a large toy story land as we speak. We have not announced a date, but it is under construction. We believe given the success of , and interest in the land, you will see substantial expansion of this particular facility over the next five to 10 years. That is very encouraging. We have always believed there are other opportunities in china, but our First Priority has been to open this one and to do it right. Since it is less than one year old, it is premature to speculate on something we might be doing in another market in china, but we hope that opportunity presents itself. Reporter theme parks and studio, big upside. Lets talk about the things that might be disappointing, and that is espn. It has been almost two years ago that you said it was coming. There would be tapering off in espn growth. It is happening now. You have also said the digital alternative, the mobile experience, with replace that overtime. Do you have a time when that would take place or make up these alternative revenues versus to make up for what you are losing on the table . You are right to point out we were candid about this two years ago. I think moore is being made of this than it deserves. Is still a healthy and profitable business, one of the most profitable businesses. Sports that is licensed for a long time that will serve it extremely well, and serving well on the traditional platform, and starting to serve well on new platforms, and for the first seeable future. It is a product that is in demand. The fact that there is still a lot of competition for sports rights, it points out just how valuable this product is. No one has more of it than espn. What is happening is exactly what we thought would happen, and that is that there is a decrease in the number of expanded basic subs on traditional platforms. That happen for a few reasons. The basic trotted is relatively more expensive than some of the products that have launched on the new platforms, and has more channels and many people believe they need. It still dominate the business. But it is definitely decreasing. We are starting to see share , from that, the large bundle, at a price that is typically in excess of 100, the smaller bundles it are launching on mostly new platforms, overthetop digital only platforms. In some cases, platforms that are mobile friendly and userfriendly. That has attracted younger people not just because of the cost, but the usability. That goes well for us. We are seeing nice growth. But other brands are launching as well. Youtube launched there is a just ago and who hulu lunch theres last week. , but we areto say encouraged by the signs we see. We believe we have a great product offer. Distributors no live sports is imperative for them to succeed in that space, and ive is why this negotiating deals are at espn. This is the beginning, and we are feeling optimistic. Reaction to it suggests otherwise, but thats not the case. We have taken a number of steps to contend with what we are seeing. It is something we have been working on for a few years. I think it is high time people start looking at espn in a positive way and not a negative way. Think about how mobile devices are being used, and what for. That live sports window, or the player that has live sports on it, is very valuable when you have a smartphone or tablet, weather in your office, in the bus, or wherever. I think that the pessimism about espn is highly exaggerated. Reporter thank you very much. Im running out of time. I have a lot more questions, but i appreciate you taking the time. Caroline fascinating conversation. David westin, thank you, with none other than bob iger. Much more ahead. Caroline welcome back. A recap of breaking news, james comey has been removed as the head of the fbi, from the white house. The attorney general gave this recommendation to donald trump. James comey is no longer at the fbi. That is it from boston. Plenty more this week Bloomberg Technology. From thats plenty more this week from Bloomberg Technology. 7 change at the fbi. President trump fires fbi director james comey. Victory in south korea, promising to unite the country after nine years of conservative rule. Australia pushes the nationbuilding budget, promising jobs and growth. Surplus projections relying heavily on higher wages. A market milestone. 10 years of the iphone sees apples vae